Melita Sun Jung

Melita Sun Jung is an accomplished business executive currently serving as the Chief Business Officer at Terns Pharmaceuticals since 2024 and as a member of Chief, an organization dedicated to empowering senior women leaders, since 2021. Previously, Melita held the position of Chief Business Officer at Structure Therapeutics from 2021 to 2023 and served as Senior Vice President and Head of Business Development at Sangamo Therapeutics, Inc. from 2017 to 2021. Melita's extensive experience in the biopharmaceutical industry includes roles such as Senior Director of Corporate Development at Adamas Pharmaceuticals, Vice President of Business Development at Ascendancy Healthcare, and Senior Product Manager at Ipsen, among others. Melita holds a Bachelor of Arts degree in Biology and Philosophy from the University of California, Berkeley.